Condition
Homozygous Familial Hypercholesterolemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Homozygous Familial Hypercholesterolemia clinical trials that are recruiting, at sites in 6 countries (most in United States (3), China (1), Denmark (1)). By phase: Early Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest Homozygous Familial Hypercholesterolemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Zodasiran for teens with homozygous familial hypercholesterolemia | Phase 3 | St Louis, Missouri and 2 other locations | Recruiting | Mar 16, 2026 |
| Gene therapy for treating a rare cholesterol disorder | Early Phase 1 | Xi'an, Shaanxi | Recruiting | Nov 9, 2023 |
| Registry for patients with homozygous familial hypercholesterolemia | — | Philadelphia, Pennsylvania and 3 other locations | Recruiting | Mar 24, 2021 |
| A repository for monitoring health in patients with homozygous familial hypercholesterolemia | — | New York, New York | Recruiting | Apr 23, 2010 |
All recruiting trials (4)
-
Zodasiran for teens with homozygous familial hypercholesterolemia
This study tests whether subcutaneous Zodasiran can help adolescents with HoFH who have very high LDL-C despite lipid-lowering therapy.
-
Gene therapy for treating a rare cholesterol disorder
This study is testing a new gene therapy to see if it can help people with a rare cholesterol disorder called homozygous familial hypercholesterolemia lower their cholesterol levels.
-
Registry for patients with homozygous familial hypercholesterolemia
This study is creating a registry to collect health information from people with homozygous familial hypercholesterolemia to better understand this rare condition and improve future treatments.
-
A repository for monitoring health in patients with homozygous familial hypercholesterolemia
This study is trying to gather health information from people with homozygous familial hypercholesterolemia to better understand their condition and find ways to improve their treatment.
Quick answers
How many Homozygous Familial Hypercholesterolemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), China (1 trial), Denmark (1 trial), Poland (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.